Literature DB >> 17420070

Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: relationship with the progression of Alzheimer's disease.

Afia Akram1, Daniel Christoffel, Anne B Rocher, Constantin Bouras, Enikö Kövari, Daniel P Perl, John H Morrison, François R Herrmann, Vahram Haroutunian, Panteleimon Giannakopoulos, Patrick R Hof.   

Abstract

The loss of presynaptic markers is thought to represent a strong pathologic correlate of cognitive decline in Alzheimer's disease (AD). Spinophilin is a postsynaptic marker mainly located to the heads of dendritic spines. We assessed total numbers of spinophilin-immunoreactive puncta in the CA1 and CA3 fields of hippocampus and area 9 in 18 elderly individuals with various degrees of cognitive decline. The decrease in spinophilin-immunoreactivity was significantly related to both Braak neurofibrillary tangle (NFT) staging and clinical severity but not A beta deposition staging. The total number of spinophilin-immunoreactive puncta in CA1 field and area 9 were significantly related to MMSE scores and predicted 23.5 and 61.9% of its variability. The relationship between total number of spinophilin-immunoreactive puncta in CA1 field and MMSE scores did not persist when adjusting for Braak NFT staging. In contrast, the total number of spinophilin-immunoreactive puncta in area 9 was still significantly related to the cognitive outcome explaining an extra 9.6% of MMSE and 25.6% of the Clinical Dementia Rating scores variability. Our data suggest that neocortical dendritic spine loss is an independent parameter to consider in AD clinicopathologic correlations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420070      PMCID: PMC2569870          DOI: 10.1016/j.neurobiolaging.2007.03.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  82 in total

1.  Comparison of four staining methods on the detection of neuritic plaques.

Authors:  H M Wisniewski; G Y Wen; K S Kim
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  A high ratio of chromogranin A to synaptin/synaptophysin is a common feature of brains in Alzheimer and Pick disease.

Authors:  R Weiler; H Lassmann; P Fischer; K Jellinger; H Winkler
Journal:  FEBS Lett       Date:  1990-04-24       Impact factor: 4.124

3.  Synaptic loss in Alzheimer's disease and other dementias.

Authors:  J E Hamos; L J DeGennaro; D A Drachman
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

4.  A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease.

Authors:  C A Davies; D M Mann; P Q Sumpter; P O Yates
Journal:  J Neurol Sci       Date:  1987-04       Impact factor: 3.181

5.  Changes in the structure of synapses associated with learning.

Authors:  G Horn; P Bradley; B J McCabe
Journal:  J Neurosci       Date:  1985-12       Impact factor: 6.167

6.  A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease.

Authors:  J H Morrison; D A Lewis; M J Campbell; G W Huntley; D L Benson; C Bouras
Journal:  Brain Res       Date:  1987-07-28       Impact factor: 3.252

7.  Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease.

Authors:  E Masliah; R D Terry; R M DeTeresa; L A Hansen
Journal:  Neurosci Lett       Date:  1989-08-28       Impact factor: 3.046

8.  A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining.

Authors:  H Yamaguchi; S Hirai; M Morimatsu; M Shoji; Y Ihara
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

9.  Monoclonal antibody to neurofilament protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey neocortex.

Authors:  M J Campbell; J H Morrison
Journal:  J Comp Neurol       Date:  1989-04-08       Impact factor: 3.215

10.  Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.

Authors:  D W Dickson; J Farlo; P Davies; H Crystal; P Fuld; S H Yen
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

View more
  42 in total

1.  BACE1 elevation is associated with aberrant limbic axonal sprouting in epileptic CD1 mice.

Authors:  Xiao-Xin Yan; Yan Cai; Xue-Mei Zhang; Xue-Gang Luo; Huaibin Cai; Gregory M Rose; Peter R Patrylo
Journal:  Exp Neurol       Date:  2012-01-11       Impact factor: 5.330

Review 2.  Structural and synaptic plasticity in stress-related disorders.

Authors:  Daniel J Christoffel; Sam A Golden; Scott J Russo
Journal:  Rev Neurosci       Date:  2011       Impact factor: 4.353

3.  Reduced dendritic spine density in auditory cortex of subjects with schizophrenia.

Authors:  Robert A Sweet; Ruth A Henteleff; Wei Zhang; Allan R Sampson; David A Lewis
Journal:  Neuropsychopharmacology       Date:  2008-05-07       Impact factor: 7.853

Review 4.  A Close Look at BACE1 Inhibitors for Alzheimer's Disease Treatment.

Authors:  Brati Das; Riqiang Yan
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

5.  Spine pruning in 5xFAD mice starts on basal dendrites of layer 5 pyramidal neurons.

Authors:  Sarah E Crowe; Graham C R Ellis-Davies
Journal:  Brain Struct Funct       Date:  2013-02-17       Impact factor: 3.270

6.  Microglia changes associated to Alzheimer's disease pathology in aged chimpanzees.

Authors:  Melissa K Edler; Chet C Sherwood; Richard S Meindl; Emily L Munger; William D Hopkins; John J Ely; Joseph M Erwin; Daniel P Perl; Elliott J Mufson; Patrick R Hof; Mary Ann Raghanti
Journal:  J Comp Neurol       Date:  2018-11-16       Impact factor: 3.215

7.  Synaptic protein deficits are associated with dementia irrespective of extreme old age.

Authors:  Michal Schnaider Beeri; Vahram Haroutunian; James Schmeidler; Mary Sano; Peter Fam; Aaron Kavanaugh; Alasdair M Barr; William G Honer; Pavel Katsel
Journal:  Neurobiol Aging       Date:  2011-12-27       Impact factor: 4.673

8.  Changes in dendritic complexity and spine morphology in transgenic mice expressing human wild-type tau.

Authors:  Dara L Dickstein; Hannah Brautigam; Steven D Stockton; James Schmeidler; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2010-03-07       Impact factor: 3.270

9.  Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system.

Authors:  Brian P Head; Hemal H Patel; Ingrid R Niesman; John C Drummond; David M Roth; Piyush M Patel
Journal:  Anesthesiology       Date:  2009-04       Impact factor: 7.892

10.  Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice.

Authors:  Tobias Bittner; Martin Fuhrmann; Steffen Burgold; Simon M Ochs; Nadine Hoffmann; Gerda Mitteregger; Hans Kretzschmar; Frank M LaFerla; Jochen Herms
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.